Impact of Difluoromethylornithine and AMXT 1501 on Gene Expression and Capsule Regulation in Streptococcus pneumoniae
Moses B Ayoola1, Leslie A Shack1, Otto Phanstiel2
1Department of Comparative Biomedical Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, MS 39762, USA.
Abstract:
Streptococcus pneumoniae (Spn), a Gram-positive bacterium, poses a significant threat to human health, causing mild respiratory infections to severe invasive conditions. Despite the availability of vaccines, challenges persist due to serotype replacement and antibiotic resistance, emphasizing the need for alternative therapeutic strategies. This study explores the intriguing role of polyamines, ubiquitous, small organic cations, in modulating virulence factors, especially the capsule, a crucial determinant of Spn's pathogenicity. Using chemical inhibitors, difluoromethylornithine (DFMO) and AMXT 1501, this research unveils distinct regulatory effects on the gene expression of the Spn D39 serotype in response to altered polyamine homeostasis. DFMO inhibits polyamine biosynthesis, disrupting pathways associated with glucose import and the interconversion of sugars. In contrast, AMXT 1501, targeting polyamine transport, enhances the expression of polyamine and glucose biosynthesis genes, presenting a novel avenue for regulating the capsule independent of glucose availability. Despite ample glucose availability, AMXT 1501 treatment downregulates the glycolytic pathway, fatty acid synthesis, and ATP synthase, crucial for energy production, while upregulating two-component systems responsible for stress management. This suggests a potential shutdown of energy production and capsule biosynthesis, redirecting resources towards stress management. Following DFMO and AMXT 1501 treatments, countermeasures, such as upregulation of stress response genes and ribosomal protein, were observed but appear to be insufficient to overcome the deleterious effects on capsule production. This study highlights the complexity of polyamine-mediated regulation in S. pneumoniae, particularly capsule biosynthesis. Our findings offer valuable insights into potential therapeutic targets for modulating capsules in a polyamine-dependent manner, a promising avenue for intervention against S. pneumoniae infections.
Insights
Polyamines regulate the capsule of Streptococcus pneumoniae (Spn). Inhibiting polyamine synthesis or transport impacts Spn
Area of Science:
- Microbiology
- Molecular Biology
- Biochemistry
Background:
- Streptococcus pneumoniae (Spn) causes significant human health issues, with vaccines facing challenges from serotype replacement and antibiotic resistance.
- Polyamines, essential organic cations, play a critical role in bacterial virulence, particularly in regulating the Spn capsule, a key pathogenicity factor.
- The need for alternative therapeutic strategies against Spn infections is driven by existing vaccine limitations and rising antibiotic resistance.
Purpose of the Study:
- To investigate the role of polyamines in modulating Streptococcus pneumoniae virulence factors, focusing on capsule biosynthesis.
- To explore the distinct effects of polyamine biosynthesis inhibitor (DFMO) and polyamine transport inhibitor (AMXT 1501) on Spn gene expression and capsule production.
- To identify potential therapeutic targets within polyamine-dependent pathways for controlling Spn infections.
Main Methods:
- Utilized chemical inhibitors difluoromethylornithine (DFMO) and AMXT 1501 to alter polyamine homeostasis in Streptococcus pneumoniae D39 serotype.
- Analyzed gene expression changes related to polyamine and glucose metabolism, energy production pathways (glycolysis, ATP synthase), and stress response systems.
- Assessed the impact of polyamine modulation on capsule biosynthesis and bacterial stress management.
Main Results:
- DFMO inhibited polyamine biosynthesis, affecting glucose import and sugar interconversion pathways, leading to reduced capsule production.
- AMXT 1501 enhanced polyamine and glucose biosynthesis gene expression but paradoxically downregulated glycolysis, fatty acid synthesis, and ATP synthase, suggesting energy redirection.
- Both treatments triggered stress response mechanisms, but these were insufficient to fully counteract the negative effects on capsule formation.
Conclusions:
- Polyamines intricately regulate Streptococcus pneumoniae capsule biosynthesis, offering a novel therapeutic target.
- Altering polyamine homeostasis through inhibitors like DFMO and AMXT 1501 significantly impacts Spn virulence factors and energy metabolism.
- Targeting polyamine-dependent pathways presents a promising strategy for developing new interventions against Spn infections, independent of traditional antibiotic or vaccine approaches.
Related Concept Videos
01:28Gene Regulation in Microbial Communities: Quorum Sensing
01:25Mechanism of Antibiotic Resistance in MRSA
01:25Clinical Significance of Antibiotic Resistance